Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Gross Profit (2023 - 2025)

Historic Gross Profit for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $1.9 million.

  • Tonix Pharmaceuticals Holding's Gross Profit rose 5177.58% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 5089.67%. This contributed to the annual value of $2.3 million for FY2024, which is 2305.91% down from last year.
  • Tonix Pharmaceuticals Holding's Gross Profit amounted to $1.9 million in Q3 2025, which was up 5177.58% from -$1.3 million recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's 5-year Gross Profit high stood at $1.9 million for Q3 2025, and its period low was -$1.3 million during Q2 2025.
  • In the last 3 years, Tonix Pharmaceuticals Holding's Gross Profit had a median value of $1.4 million in 2024 and averaged $832333.3.
  • In the last 5 years, Tonix Pharmaceuticals Holding's Gross Profit tumbled by 2154.8% in 2024 and then surged by 8077.86% in 2025.
  • Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Gross Profit stood at $1.4 million in 2023, then dropped by 0.92% to $1.4 million in 2024, then skyrocketed by 37.46% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, -$1.3 million for Q2 2025, and $1.5 million during Q1 2025.